跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VALPROATE-AFT sodium valproate 300 mg/3 ml solution for intravenous infusion or injection vials - TGA Drug Approval Details
Approvals
/
TGA
/
VALPROATE-AFT sodium valproate 300 mg/3 ml solution for intravenous infusion or injection vials
Approved
STANDARD
VALPROATE-AFT sodium valproate 300 mg/3 ml solution for intravenous infusion or injection vials
AFT Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
71df600e6413abcd
Company
AFT Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
71df600e6413abcd
Product Name
VALPROATE-AFT sodium valproate 300 mg/3 ml solution for intravenous infusion or injection vials
Artg Id
297324
Artg Name
VALPROATE-AFT sodium valproate 300 mg/3 ml solution for injection vials
Sponsor
AFT Pharmaceuticals Pty Ltd
Company Detail Path
/organization/aft-pharmaceuticals-au-pty-ltd
Artg Date
2019-02-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/171c5f5a6d0cab711cf990d6f5972551.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/dc9ed273365d0e794e38b3c8f4f5588f.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
71df600e6413abcd
Type
Standard
Back to TGA Approvals